Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study

INTRODUCTION: Patients with distributive shock who require high dose vasopressors have a high mortality. Angiotensin II (ATII) may prove useful in patients who remain hypotensive despite catecholamine and vasopressin therapy. The appropriate dose of parenteral angiotensin II for shock is unknown. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chawla, Lakhmir S, Busse, Laurence, Brasha-Mitchell, Ermira, Davison, Danielle, Honiq, Jacqueline, Alotaibi, Ziyad, Seneff, Michael G
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212099/
https://ncbi.nlm.nih.gov/pubmed/25286986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-014-0534-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados